Cn / En

CM05363


CM05363

Key word结直肠癌, PDX, 体内药效,体外药效,免疫系统人源化,5-FU, DM1, DS8201, DXD, SN38, TAS-102, 奥沙利铂, 奥希替尼, 多西他赛, 恩考拉非尼, 吉西他滨, 拉帕替尼, 雷替曲塞, 芦康莎妥珠单抗, 曲美替尼, 顺铂, 丝裂霉素C, 依维莫司, 长春新碱, 紫杉醇,

Model Information

Model IDCM05363
Cancer Type结直肠癌(原位)
Cell Subtype腺癌
Differentiation中低分化
Collection Site直肠
Metastatic Site原位
Grade 
TNM stagingT3N1bM0
IHC diagnosisMLH1(+), MSH2(+), MSH6(+), PMS2(+), S-100染色提示神经侵犯, CD34、D2-40染色提示脉管侵犯, Ki-67增殖指数约80%
Pathology diagnosis侵及浆膜下层;两侧切缘及环周切缘未查见癌组织,肠系膜淋巴结(3/21)查见转移癌,周围黏膜未见明显异常。,
Clinical Treatment Records 

Model Data

Histopathological Images

 

Tumor growth curve

In vivo efficacy of SOCs

  
  
  
  

In vitro efficacy of SOCs